Uric acid and evaluate the coronary vascular stenosis gensini score correlation research and in gender differences.
Coronary arteriography
Coronary artery Disease
Gensini score
Serum uric acid
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
08 11 2023
08 11 2023
Historique:
received:
09
08
2023
accepted:
26
10
2023
medline:
10
11
2023
pubmed:
9
11
2023
entrez:
8
11
2023
Statut:
epublish
Résumé
Recent studies have shown that the negative effect of uric acid (UA) on coronary arteries determines the severity of atherosclerotic disease. This study aims to explore the relationship between serum UA level and Gensini score, which reflects the severity of coronary artery disease. A total of 860 patients with suspected coronary heart disease who were admitted to hospital due to angina pectoris or myocardial ischemia related symptoms and received coronary angiography were selected. Based on the findings of the angiography, they were categorized into two groups: the coronary heart disease (CHD) group (n = 625) and the control group (n = 235). The uric acid levels and other clinical data were compared between these groups. Additionally, the prevalence of coronary heart disease and Gensini score were compared between the groups, considering gender-specific quartiles of uric acid levels. The clinical baseline data were analyzed using appropriate statistical methods, and multivariate logistic regression analysis was conducted to identify independent risk factors for coronary heart disease. Of 860 patients (mean age, 63.97 ± 11.87 years), 528 were men (mean age, 62.06 ± 11.5 years) and 332 were women (mean age, 66.99 ± 10.11 years). The proportion of smoking, diabetes, hypertension, and hyperlipidemia in the coronary heart disease group was higher than that in the control group (P < 0.05). HbA1C, Gensini score, BMI, TG and hsCRP in the coronary heart disease group were higher than those in the control group (P < 0.05), and HDL-C was lower than that in the control group (P < 0.05). There were no significant differences in age, heart rate, Cr, TC and LDL-C between the two groups (P > 0.05).Multivariate logistic regression analysis showed that age, hypertension, hsCRP and SUA levels increased the risk of coronary heart disease, and the difference was statistically significant(OR = 1.034,95%CI 1.016-1.052, P = 0.001; OR = 1.469,95%CI 1.007-2.142, P = 0.046;OR = 1.064,95%CI 1.026-1.105, P = 0.001; OR = 1.011,95%CI 1.008-1.014, P < 0.001). Serum uric acid is positively correlated with Gensini score in patients with coronary heart disease, which is an independent factor for evaluating the degree of coronary artery stenosis and has a predictive effect.
Sections du résumé
BACKGROUND AND AIMS
Recent studies have shown that the negative effect of uric acid (UA) on coronary arteries determines the severity of atherosclerotic disease. This study aims to explore the relationship between serum UA level and Gensini score, which reflects the severity of coronary artery disease.
METHODS
A total of 860 patients with suspected coronary heart disease who were admitted to hospital due to angina pectoris or myocardial ischemia related symptoms and received coronary angiography were selected. Based on the findings of the angiography, they were categorized into two groups: the coronary heart disease (CHD) group (n = 625) and the control group (n = 235). The uric acid levels and other clinical data were compared between these groups. Additionally, the prevalence of coronary heart disease and Gensini score were compared between the groups, considering gender-specific quartiles of uric acid levels. The clinical baseline data were analyzed using appropriate statistical methods, and multivariate logistic regression analysis was conducted to identify independent risk factors for coronary heart disease.
RESULTS
Of 860 patients (mean age, 63.97 ± 11.87 years), 528 were men (mean age, 62.06 ± 11.5 years) and 332 were women (mean age, 66.99 ± 10.11 years). The proportion of smoking, diabetes, hypertension, and hyperlipidemia in the coronary heart disease group was higher than that in the control group (P < 0.05). HbA1C, Gensini score, BMI, TG and hsCRP in the coronary heart disease group were higher than those in the control group (P < 0.05), and HDL-C was lower than that in the control group (P < 0.05). There were no significant differences in age, heart rate, Cr, TC and LDL-C between the two groups (P > 0.05).Multivariate logistic regression analysis showed that age, hypertension, hsCRP and SUA levels increased the risk of coronary heart disease, and the difference was statistically significant(OR = 1.034,95%CI 1.016-1.052, P = 0.001; OR = 1.469,95%CI 1.007-2.142, P = 0.046;OR = 1.064,95%CI 1.026-1.105, P = 0.001; OR = 1.011,95%CI 1.008-1.014, P < 0.001).
CONCLUSION
Serum uric acid is positively correlated with Gensini score in patients with coronary heart disease, which is an independent factor for evaluating the degree of coronary artery stenosis and has a predictive effect.
Identifiants
pubmed: 37940848
doi: 10.1186/s12872-023-03581-5
pii: 10.1186/s12872-023-03581-5
pmc: PMC10634079
doi:
Substances chimiques
Uric Acid
268B43MJ25
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
546Informations de copyright
© 2023. The Author(s).
Références
High Blood Press Cardiovasc Prev. 2023 Sep;30(5):411-425
pubmed: 37792253
J Hypertens. 2015 Sep;33(9):1729-41; discussion 1741
pubmed: 26136207
Can J Physiol Pharmacol. 2016 Mar;94(3):272-7
pubmed: 26762617
BMJ. 2018 Oct 10;363:k3951
pubmed: 30305269
Atherosclerosis. 2018 Feb;269:229-235
pubmed: 29407598
Lancet. 2020 Nov 14;396(10262):1562
pubmed: 33198906
Trends Cardiovasc Med. 2015 Feb;25(2):140-51
pubmed: 25453985
Eur J Prev Cardiol. 2015 Apr;22(4):513-8
pubmed: 24431384
Lancet Diabetes Endocrinol. 2016 Apr;4(4):327-36
pubmed: 26781229
Diabetes Care. 2020 Aug;43(8):1843-1850
pubmed: 31548242
Int J Cardiol. 2014 Sep 20;176(2):550-2
pubmed: 25065332
J Atheroscler Thromb. 2014;21(12):1271-82
pubmed: 25069816
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Int J Sports Med. 2021 Jan;42(1):19-26
pubmed: 32650344
Curr Vasc Pharmacol. 2016;14(2):130-45
pubmed: 26638799
Lancet. 2022 Oct 8;400(10359):1195-1205
pubmed: 36216006
Circulation. 2016 Jan 26;133(4):e38-360
pubmed: 26673558
J Hypertens. 2010 Jun;28(6):1234-42
pubmed: 20486275
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1186-92
pubmed: 18356554
Nutr Metab Cardiovasc Dis. 2021 May 6;31(5):1501-1508
pubmed: 33810962
Nutrients. 2017 Apr 18;9(4):
pubmed: 28420204
J Assoc Physicians India. 2019 Apr;67(4):29-32
pubmed: 31311215
Curr Hypertens Rep. 2013 Jun;15(3):175-81
pubmed: 23588856
J Clin Med. 2021 Oct 16;10(20):
pubmed: 34682873
Circulation. 2019 Feb 19;139(8):1047-1056
pubmed: 30586725
Curr Opin Cardiol. 2019 Jul;34(4):399-405
pubmed: 30925517
Atherosclerosis. 2019 Aug;287:181-183
pubmed: 31104809
Sci Rep. 2015 Jun 05;5:10987
pubmed: 26046576
Indian Heart J. 2021 May-Jun;73(3):307-312
pubmed: 34154747
Heart. 2013 Jun;99(11):759-66
pubmed: 23343689
Adv Exp Med Biol. 2017;1000:3-7
pubmed: 29098612
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
High Blood Press Cardiovasc Prev. 2020 Apr;27(2):121-128
pubmed: 32157643
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 May 24;48(5):393-400
pubmed: 32450656
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
Am Heart J. 2012 Oct;164(4):547-552.e1
pubmed: 23067913
Atherosclerosis. 2018 Nov;278:226-231
pubmed: 30326405
Angiology. 2012 Aug;63(6):448-52
pubmed: 22096206
Atherosclerosis. 2017 Aug;263:325-333
pubmed: 28577936
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):570-582
pubmed: 31996020